Crossmark

Epigallocatechin-3-Gallate Inhibits Oxidative Stress Through the Keap1/Nrf2 Signaling Pathway to Improve Alzheimer Disease

Published Online: 2024-09-20

Published Print: 2025-03

Authors

Tang, Shi

Zhang, Yong

Botchway, Benson O. A.

Wang, Xichen

Huang, Min

Liu, Xuehong
License Information

Text and Data Mining valid from 2024-09-20

Version of Record valid from 2024-09-20
More Information

Article History

Received: 23 April 2024

Accepted: 12 September 2024

First Online: 20 September 2024

Declarations

:

: Not applicable.

: All authors agreed to publish this article.

: The authors declare no competing interests.

Document is current